Logo image of CCEP

COCA-COLA EUROPACIFIC PARTNE (CCEP) Stock Fundamental Analysis

NASDAQ:CCEP - Nasdaq - GB00BDCPN049 - Common Stock - Currency: USD

86.92  +0.66 (+0.77%)

After market: 86.92 0 (0%)

Fundamental Rating

3

Overall CCEP gets a fundamental rating of 3 out of 10. We evaluated CCEP against 32 industry peers in the Beverages industry. Both the profitability and financial health of CCEP have multiple concerns. CCEP is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

CCEP had positive earnings in the past year.
In the past year CCEP had a positive cash flow from operations.
In the past 5 years CCEP has always been profitable.
CCEP had a positive operating cash flow in each of the past 5 years.
CCEP Yearly Net Income VS EBIT VS OCF VS FCFCCEP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

The Return On Assets of CCEP (4.56%) is comparable to the rest of the industry.
With a decent Return On Equity value of 16.70%, CCEP is doing good in the industry, outperforming 65.52% of the companies in the same industry.
With a Return On Invested Capital value of 6.98%, CCEP perfoms like the industry average, outperforming 44.83% of the companies in the same industry.
Industry RankSector Rank
ROA 4.56%
ROE 16.7%
ROIC 6.98%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CCEP Yearly ROA, ROE, ROICCCEP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

CCEP has a Profit Margin of 6.94%. This is comparable to the rest of the industry: CCEP outperforms 44.83% of its industry peers.
In the last couple of years the Profit Margin of CCEP has declined.
Looking at the Operating Margin, with a value of 10.43%, CCEP is doing worse than 65.52% of the companies in the same industry.
In the last couple of years the Operating Margin of CCEP has declined.
CCEP has a Gross Margin of 35.28%. This is amonst the worse of the industry: CCEP underperforms 86.21% of its industry peers.
In the last couple of years the Gross Margin of CCEP has declined.
Industry RankSector Rank
OM 10.43%
PM (TTM) 6.94%
GM 35.28%
OM growth 3Y-3.06%
OM growth 5Y-4.38%
PM growth 3Y-0.93%
PM growth 5Y-5.22%
GM growth 3Y-1.9%
GM growth 5Y-1.69%
CCEP Yearly Profit, Operating, Gross MarginsCCEP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CCEP is destroying value.
CCEP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CCEP Yearly Shares OutstandingCCEP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M
CCEP Yearly Total Debt VS Total AssetsCCEP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B 20B 25B

2.2 Solvency

CCEP has an Altman-Z score of 2.21. This is not the best score and indicates that CCEP is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of CCEP (2.21) is comparable to the rest of the industry.
CCEP has a debt to FCF ratio of 5.34. This is a neutral value as CCEP would need 5.34 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 5.34, CCEP is doing good in the industry, outperforming 65.52% of the companies in the same industry.
CCEP has a Debt/Equity ratio of 1.17. This is a high value indicating a heavy dependency on external financing.
CCEP has a Debt to Equity ratio of 1.17. This is in the lower half of the industry: CCEP underperforms 68.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF 5.34
Altman-Z 2.21
ROIC/WACC0.82
WACC8.52%
CCEP Yearly LT Debt VS Equity VS FCFCCEP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 0.81 indicates that CCEP may have some problems paying its short term obligations.
The Current ratio of CCEP (0.81) is worse than 79.31% of its industry peers.
A Quick Ratio of 0.62 indicates that CCEP may have some problems paying its short term obligations.
With a Quick ratio value of 0.62, CCEP is not doing good in the industry: 68.97% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.81
Quick Ratio 0.62
CCEP Yearly Current Assets VS Current LiabilitesCCEP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

5

3. Growth

3.1 Past

The earnings per share for CCEP have decreased strongly by -15.31% in the last year.
Measured over the past 5 years, CCEP shows a small growth in Earnings Per Share. The EPS has been growing by 5.80% on average per year.
Looking at the last year, CCEP shows a quite strong growth in Revenue. The Revenue has grown by 11.67% in the last year.
The Revenue has been growing by 11.21% on average over the past years. This is quite good.
EPS 1Y (TTM)-15.31%
EPS 3Y12.68%
EPS 5Y5.8%
EPS Q2Q%-24.06%
Revenue 1Y (TTM)11.67%
Revenue growth 3Y14.09%
Revenue growth 5Y11.21%
Sales Q2Q%13.78%

3.2 Future

CCEP is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.10% yearly.
Based on estimates for the next years, CCEP will show a small growth in Revenue. The Revenue will grow by 1.19% on average per year.
EPS Next Y7.08%
EPS Next 2Y8.16%
EPS Next 3Y8.5%
EPS Next 5Y10.1%
Revenue Next Year4.53%
Revenue Next 2Y4.2%
Revenue Next 3Y4.17%
Revenue Next 5Y1.19%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CCEP Yearly Revenue VS EstimatesCCEP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
CCEP Yearly EPS VS EstimatesCCEP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4 5

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 26.99, which means the current valuation is very expensive for CCEP.
Compared to the rest of the industry, the Price/Earnings ratio of CCEP is on the same level as its industry peers.
When comparing the Price/Earnings ratio of CCEP to the average of the S&P500 Index (29.75), we can say CCEP is valued inline with the index average.
The Price/Forward Earnings ratio is 19.36, which indicates a rather expensive current valuation of CCEP.
The rest of the industry has a similar Price/Forward Earnings ratio as CCEP.
CCEP's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.44.
Industry RankSector Rank
PE 26.99
Fwd PE 19.36
CCEP Price Earnings VS Forward Price EarningsCCEP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CCEP indicates a slightly more expensive valuation: CCEP is more expensive than 62.07% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CCEP indicates a rather cheap valuation: CCEP is cheaper than 82.76% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 18.04
EV/EBITDA 15.58
CCEP Per share dataCCEP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)3.81
PEG (5Y)4.65
EPS Next 2Y8.16%
EPS Next 3Y8.5%

4

5. Dividend

5.1 Amount

CCEP has a Yearly Dividend Yield of 2.47%.
Compared to an average industry Dividend Yield of 3.17, CCEP has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.30, CCEP has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.47%

5.2 History

The dividend of CCEP is nicely growing with an annual growth rate of 11.43%!
CCEP has been paying a dividend for at least 10 years, so it has a reliable track record.
CCEP has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)11.43%
Div Incr Years4
Div Non Decr Years4
CCEP Yearly Dividends per shareCCEP Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.5 1 1.5 2

5.3 Sustainability

CCEP pays out 64.17% of its income as dividend. This is not a sustainable payout ratio.
CCEP's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP64.17%
EPS Next 2Y8.16%
EPS Next 3Y8.5%
CCEP Yearly Income VS Free CF VS DividendCCEP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
CCEP Dividend Payout.CCEP Dividend Payout, showing the Payout Ratio.CCEP Dividend Payout.PayoutRetained Earnings

COCA-COLA EUROPACIFIC PARTNE

NASDAQ:CCEP (3/3/2025, 8:17:47 PM)

After market: 86.92 0 (0%)

86.92

+0.66 (+0.77%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)02-14 2025-02-14/amc
Earnings (Next)N/A N/A
Inst Owners35.56%
Inst Owner Change3.67%
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap40.07B
Analysts79.13
Price Target89.21 (2.63%)
Short Float %1.83%
Short Ratio2.26
Dividend
Industry RankSector Rank
Dividend Yield 2.47%
Yearly Dividend1.91
Dividend Growth(5Y)11.43%
DP64.17%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.54%
PT rev (3m)2.49%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.09%
EPS NY rev (3m)-0.62%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.19%
Revenue NY rev (3m)0.07%
Valuation
Industry RankSector Rank
PE 26.99
Fwd PE 19.36
P/S 1.87
P/FCF 18.04
P/OCF 12.51
P/B 4.51
P/tB N/A
EV/EBITDA 15.58
EPS(TTM)3.22
EY3.7%
EPS(NY)4.49
Fwd EY5.17%
FCF(TTM)4.82
FCFY5.54%
OCF(TTM)6.95
OCFY8%
SpS46.4
BVpS19.27
TBVpS-20.31
PEG (NY)3.81
PEG (5Y)4.65
Profitability
Industry RankSector Rank
ROA 4.56%
ROE 16.7%
ROCE 9.29%
ROIC 6.98%
ROICexc 7.55%
ROICexgc 42.15%
OM 10.43%
PM (TTM) 6.94%
GM 35.28%
FCFM 10.38%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-3.06%
OM growth 5Y-4.38%
PM growth 3Y-0.93%
PM growth 5Y-5.22%
GM growth 3Y-1.9%
GM growth 5Y-1.69%
F-Score5
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF 5.34
Debt/EBITDA 3.24
Cap/Depr 100.64%
Cap/Sales 4.59%
Interest Coverage 8.56
Cash Conversion 99.87%
Profit Quality 149.65%
Current Ratio 0.81
Quick Ratio 0.62
Altman-Z 2.21
F-Score5
WACC8.52%
ROIC/WACC0.82
Cap/Depr(3y)92.36%
Cap/Depr(5y)78.04%
Cap/Sales(3y)4.17%
Cap/Sales(5y)3.92%
Profit Quality(3y)141.19%
Profit Quality(5y)162.2%
High Growth Momentum
Growth
EPS 1Y (TTM)-15.31%
EPS 3Y12.68%
EPS 5Y5.8%
EPS Q2Q%-24.06%
EPS Next Y7.08%
EPS Next 2Y8.16%
EPS Next 3Y8.5%
EPS Next 5Y10.1%
Revenue 1Y (TTM)11.67%
Revenue growth 3Y14.09%
Revenue growth 5Y11.21%
Sales Q2Q%13.78%
Revenue Next Year4.53%
Revenue Next 2Y4.2%
Revenue Next 3Y4.17%
Revenue Next 5Y1.19%
EBIT growth 1Y-5.24%
EBIT growth 3Y10.6%
EBIT growth 5Y6.34%
EBIT Next Year54.11%
EBIT Next 3Y19.04%
EBIT Next 5Y12.31%
FCF growth 1Y6.42%
FCF growth 3Y8.29%
FCF growth 5Y10.26%
OCF growth 1Y9.09%
OCF growth 3Y13.08%
OCF growth 5Y9.96%